Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Retrospective analysis of high-dose-rate brachytherapy for patients with prostate cancer aged 75 years
HDR-BT for older group (≥ 75 years) not associated with adverse events.
»
01/07/26
Leveraging the germ layer development patterns to predict prognosis and identify MEST as a novel therapeutic target in glioma
MEST might promote glioma development through activating RAS signaling.
»
01/07/26
Recreational physical activity and biomarkers of breast cancer risk in a cohort of adolescent girls
RPA associated with BTC and oxidative stress.
»
01/07/26
HDAC6 orchestrates metastatic and immunosuppressive programs in small cell lung cancer through S100A2-TGF-β/SMAD and CSF1R signaling
HDAC6 polarized macrophages toward tumor-promoting M2 phenotypes.
»
01/07/26
Green tea catechins and prostate cancer: mechanisms, clinical evidence, and safety: a narrative review
EGCG may aid in PCa prevention and management.
»
01/08/26
PARP1 trapping activates cGAS-STING pathway to induce immunogenic cell death in multiple myeloma
Significant correlation between hyperactivation of cGAS-STING mRNA signature and poor PFS and OS in MM.
»
01/08/26
PROTAC-mediated degradation of Bcl-xL potentiates target therapy in preclinical melanoma models
Mcl-1 specific inhibitor, S63845, potentiated efficacy of DT2216 in melanoma cells.
»
01/08/26
BACE2 tunes lipid uptake through lipid transporters shedding supporting cancer cell proliferation
Strong positive correlation between BACE2 expression, lipid metabolism and lipid droplets accumulation.
»
01/08/26
NSD2 upregulation is driven by high-risk HPV E6/E7 and disrupts epithelial differentiation in HPV-associated head and neck cancer
HPV+ HNSCC exhibited elevated H3K36me2 levels.
»
01/08/26
Bone mineral density as a prognostic marker in patients with non-small cell lung cancer undergoing neoadjuvant chemoimmunotherapy
Prognostic value for BMD confirmed through RCS analysis.
»
01/08/26
< Prev
Next >